Consegna Pharma Inc.
PrivateLast Round
Grant
Sep 15, 2023
Total Funding Raised
$3.09M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Consegna Pharma Inc. operates in Healthcare & Life Sciences and is based in Pittsburgh, Pennsylvania. Its latest recorded funding round was a Grant round in September 2023.
Consegna Pharma Inc. is a biopharmaceutical company that develops long-acting injectable medications by reformulating known, FDA-approved drugs to improve clinical outcomes and patient adherence.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Consegna Pharma Inc. Comparables
Compare Consegna Pharma Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Elysium Therapeutics | 85% | |
| Trekka Therapeutics, Inc. | 77% | |
| Braeburn Inc. | 73% |
For institutional investors. Book with your work email.
Consegna Pharma Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 15, 2023 | ||||
| Grant | Sep 30, 2022 | ||||
| Grant | Nov 19, 2019 |
For institutional investors. Book with your work email.
Consegna Pharma Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute on Drug Abuse | Grant |
| University of Pittsburgh Innovation Institute | Accelerator |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 228% MoM.
- Jul 25, 2026
Monthly visitors increased 235% MoM, from 65 to 218.
For institutional investors. Book with your work email.
Consegna Pharma Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Consegna Pharma Inc.'s valuation, stock price, and market status.
Is Consegna Pharma Inc. a public or private company?
Consegna Pharma Inc. is a private company.
What is the current stock price of Consegna Pharma Inc.?
Consegna Pharma Inc. is a private company, so its shares have no public market price. Caplight tracks Consegna Pharma Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Consegna Pharma Inc. worth (valuation)?
Valuation information for Consegna Pharma Inc. is not publicly available.
Can I buy Consegna Pharma Inc. stock?
Consegna Pharma Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Consegna Pharma Inc.'s last funding round?
Consegna Pharma Inc.'s most recent funding round was Grant on September 15, 2023.
Who are the main investors in Consegna Pharma Inc.?
Key investors in Consegna Pharma Inc. include National Institute on Drug Abuse, University of Pittsburgh Innovation Institute, National Institutes of Health (NIH).
Will Consegna Pharma Inc. IPO soon?
No public IPO plans have been announced for Consegna Pharma Inc..
How can I track Consegna Pharma Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Consegna Pharma Inc.'s shares on secondary markets.